Cancer medication combinations pose unique bioequivalence challenges for generics. Small changes in drug absorption can affect safety and efficacy. Learn how regulators, hospitals, and manufacturers are adapting to ensure affordable cancer care without compromising outcomes.
© 2026. All rights reserved.